Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy

Journal of the American College of Cardiology

Volumn 66, Issue 18, 2015, Pages 1990-1999

  Karantalis, Vasileios ^a   Suncion Loescher, Viky Y ^a   Bagno, Luiza ^a   Golpanian, Samuel ^a   Wolf, Ariel ^a   Sanina, Cristina ^a   Premer, Courtney ^a   Kanelidis, Anthony J ^a   McCall, Frederic ^a   Wang, Bo ^a   Balkan, Wayne ^a   Rodriguez, Jose ^a   Rosado, Marcos ^a   Morales, Azorides ^a   Hatzistergos, Konstantinos ^a   Natsumeda, Makoto ^a   Margitich, Irene ^a   Schulman, Ivonne Hernandez ^a   Gomes, Samirah A ^a   Mushtaq, Muzammil ^a   DiFede, Darcy L ^a   Fishman, Joel E ^a   Pattany, Pradip ^a   Zambrano, Juan Pablo ^b   Heldman, Alan W ^a   Hare, Joshua M ^a   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Jackson South Community Hospital   (United States)

Author keywords

cardiac; combination therapy; heart failure; mesenchymal stem cell

Indexed keywords

PLACEBO; STEM CELL FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARDIAC STEM CELL TRANSPLANTATION; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC ISCHEMIC CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLE; FEMALE; GOTTINGEN MINIPIG; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART OUTPUT; HEART PERFORMANCE; HEART STROKE VOLUME; HEART VENTRICLE WALL MOTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOSIS; NONHUMAN; PATIENT SAFETY; PORCINE MODEL; PRIORITY JOURNAL; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; BIOLOGICAL THERAPY; CARDIAC MYOBLAST; CARDIOMYOPATHIES; CINE MAGNETIC RESONANCE IMAGING; COMPLICATION; HEART VENTRICLE REMODELING; HETEROTOPIC TRANSPLANTATION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOPHYSIOLOGY; PIG; PROCEDURES; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CARDIOMYOPATHIES; CELL- AND TISSUE-BASED THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLASTS, CARDIAC; MYOCARDIAL REPERFUSION INJURY; STROKE VOLUME; SWINE; TRANSPLANTATION, HETEROTOPIC; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84942457205     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.879     Document Type: Article

References (46)

1. J.M. Hare, J.E. Fishman, G. Gerstenblith, and et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial JAMA 308 2012 2369 2379
2. A.W. Heldman, D. DiFede, J.E. Fishman, and et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial JAMA 311 2014 62 73
3. V. Karantalis, and J.M. Hare Use of mesenchymal stem cells for therapy of cardiac disease Circ Res 116 2015 1413 1430
4. A.R. Williams, and J.M. Hare Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Circ Res 109 2011 923 940
5. L.C. Amado, A.P. Saliaris, K.H. Schuleri, and et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction Proc Natl Acad Sci U S A 102 2005 11474 11479
6. K.H. Schuleri, G.S. Feigenbaum, M. Centola, and et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy Eur Heart J 30 2009 2722 2732
7. V.Y. Suncion, I.H. Schulman, and J.M. Hare Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy Stem Cells Transl Med 1 2012 29 35
8. K. Malliaras, R.R. Makkar, R.R. Smith, and et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) J Am Coll Cardiol 63 2014 110 122
9. E.C. Perin, K.M. Borow, G.V. Silva, and et al. A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or non-ischemic heart failure Circ Res 117 2015 576 584
10. C. Sanina, and J.M. Hare Mesenchymal stem cells as a biological drug for heart disease: where are we with cardiac cell-based therapy? Circ Res 117 2015 229 233
11. A.R. Williams, K.E. Hatzistergos, B. Addicott, and et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and restore cardiac function after myocardial infarction Circulation 127 2013 213 223
12. F.C. McCall, K.S. Telukuntla, V. Karantalis, and et al. Myocardial infarction and intramyocardial injection models in swine Nat Protoc 7 2012 1479 1496
13. F.S. Angeli, M. Shapiro, N. Amabile, and et al. Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy Comp Med 59 2009 272 279
14. H. Mahrholdt, A. Wagner, T.A. Holly, and et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging Circulation 106 2002 2322 2327
15. R.J. Jankowski, C. Haluszczak, M. Trucco, and J. Huard Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells Hum Gene Ther 12 2001 619 628
16. P.V. Johnston, T. Sasano, K. Mills, and et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy Circulation 120 2009 1075 1083
17. B.N. Oskouei, G. Lamirault, C. Joseph, and et al. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair Stem Cells Transl Med 1 2012 116 124
18. M. Gyongyosi, and N. Dib Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease Nat Rev Cardiol 8 2011 393 404
19. Y. Liu, Y. Xiong, D. Liu, and et al. The effect of enhanced external counterpulsation on C-reactive protein and flow-mediated dilation in porcine model of hypercholesterolaemia Clin Physiol Funct Imaging 32 2012 262 267
20. M.F. Berry, A.J. Engler, Y.J. Woo, and et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance Am J Physiol Heart Circ Physiol 290 2006 H2196 H2203
21. M. Gnecchi, Z. Zhang, A. Ni, and V.J. Dzau Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 2008 1204 1219
22. S. Ohnishi, H. Sumiyoshi, S. Kitamura, and N. Nagaya Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions FEBS Lett 581 2007 3961 3966
23. G.V. Silva, S. Litovsky, J.A. Assad, and et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model Circulation 111 2005 150 156
24. Y.L. Tang, Q. Zhao, Y.C. Zhang, and et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium Regul Pept 117 2004 3 10
25. K.E. Hatzistergos, H. Quevedo, B.N. Oskouei, and et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation Circ Res 107 2010 913 922
26. C. Nakanishi, M. Yamagishi, K. Yamahara, and et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells Biochem Biophys Res Commun 374 2008 11 16
27. H.C. Quevedo, K.E. Hatzistergos, B.N. Oskouei, and et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity Proc Natl Acad Sci U S A 106 2009 14022 14027
28. Y. Zhou, S. Wang, Z. Yu, R.F. Hoyt Jr., X. Qu, and K.A. Horvath Marrow stromal cells differentiate into vasculature after allogeneic transplantation into ischemic myocardium Ann Thorac Surg 91 2011 1206 1212
29. S. Windmolders, A. De Boeck, R. Koninckx, and et al. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident cardiac atrial appendage stem cells J Mol Cell Cardiol 66 2014 177 188
30. K. Urbanek, D. Cesselli, M. Rota, and et al. Stem cell niches in the adult mouse heart Proc Natl Acad Sci U S A 103 2006 9226 9231
31. R. Mazhari, and J.M. Hare Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche Nature Clin Practice Cardiovasc Med 4 Suppl 1 2007 S21 S26
32. F. Buron, H. Perrin, C. Malcus, and et al. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells Transplant Proc 41 2009 3347 3352
33. D. Shi, L. Liao, B. Zhang, and et al. Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through jagged-1-mediated inhibition of NF-kappaB signaling Exp Hematol 39 2011 214 224.e1
34. R. Maccario, A. Moretta, A. Cometa, and et al. Human mesenchymal stem cells and cyclosporin A exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes Biol Blood Marrow Transplant 11 2005 1031 1032
35. C.F. Azevedo, L.C. Amado, D.L. Kraitchman, and et al. Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging Eur Heart J 25 2004 1419 1427
36. Y. Kitta, J.E. Obata, T. Nakamura, and et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease J Am Coll Cardiol 53 2009 323 330
37. C. Premer, A. Blum, M. Bellio, and et al. Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells EBioMedicine 2 2015 467 475
38. V. Karantalis, I.H. Schulman, W. Balkan, and J.M. Hare Allogeneic cell therapy: a new paradigm in therapeutics Circ Res 116 2015 12 15
39. V. Karantalis, W. Balkan, I.H. Schulman, K.E. Hatzistergos, and J.M. Hare Cell-based therapy for prevention and reversal of myocardial remodeling Am J Physiol Heart Circ Physiol 303 2012 H256 H270
40. R. Bolli, A.R. Chugh, D. D'Amario, and et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial Lancet 378 2011 1847 1857
41. G.M. Ellison, C. Vicinanza, A.J. Smith, and et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair Cell 154 2013 827 842
42. J.H. van Berlo, O. Kanisicak, M. Maillet, and et al. C-kit cells minimally contribute cardiomyocytes to the heart Nature 509 2014 337 341
43. J.H. van Berlo, and J.D. Molkentin An emerging consensus on cardiac regeneration Nat Med 20 2014 1386 1393
44. Z. Lin, and W.T. Pu Strategies for cardiac regeneration and repair Sci Transl Med 6 2014 239rv1
45. K.E. Hatzistergos, L.M. Takeuchi, D. Saur, and et al. cKit+ Cardiac Progenitors of Neural Crest Origin Proc Natl Acad Sci USA 2015 [E-pub ahead of print]
46. T. Konfino, N. Landa, T. Ben-Mordechai, and J. Leor The type of injury dictates the mode of repair in neonatal and adult heart J Am Heart Assoc 4 2015 e001320